H Kared, S Martelli, TP Ng,
SLF Pender… - Cancer Immunology …, 2016 - Springer
The CD57 antigen (alternatively HNK-1, LEU-7, or L2) is routinely used to identify terminally
differentiated 'senescent'cells with reduced proliferative capacity and altered functional …